New IVD Flu/RSV/SARS-CoV-2 Control Panel from Microbiologics

New IVD Flu/RSV/SARS-CoV-2 Control Panel from Microbiologics

October 29, 2020

With the world facing the most challenging health crisis in a century, we are now entering flu season. No one can predict what will happen when flu meets COVID-19. The similar symptomatology may further strain the healthcare system. This makes the availability of tests and controls for four major respiratory viruses, including COVID-19, crucial to the health care system to allow doctors to quickly respond with the right diagnoses and treatments.

Flu/RSV/SARS-CoV-2 Control Panel (Inactivated Swab) can be used to monitor the extraction, amplification and detection of Influenza A, Influenza B, Respiratory Syncytial Virus, and SARS-CoV-2 Virus molecular applications. Routine use of external quality controls monitor day to day performance of molecular testing procedures.

New TP53 MASTR

New TP53 MASTR

Multiplicom is pleased to announce the release of the TP53 MASTR molecular assay for the identification of mutations in the entire coding region of TP53.




September 29, 2015 More +
Blood-based biomarkers for COVID-19

Blood-based biomarkers for COVID-19

Establishing biomarkers for COVID-19 that indicate which patients are likely to develop severe disease could help clinicians to categorize patients earlier, improve prognosis and prioritize treatment.

June 23, 2020 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us